FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1132311000001102: Salicylic acid 3% / Betamethasone dipropionate 0.05% ointment 30 gram (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21667701000001114 Salicylic acid 3% / Betamethasone dipropionate 0.05% ointment 30 gram (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
60113301000001115 Betamethasone dipropionate 0.05% / Salicylic acid 3% ointment 30 gram en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


8 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Salicylic acid 3% / Betamethasone dipropionate 0.05% ointment 30 gram Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Salicylic acid 3% / Betamethasone dipropionate 0.05% ointment 30 gram Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Salicylic acid 3% / Betamethasone dipropionate 0.05% ointment 30 gram Is pack of Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and salicylic acid 30 milligram/1 gram conventional release cutaneous ointment false Inferred relationship Existential restriction modifier
Salicylic acid 3% / Betamethasone dipropionate 0.05% ointment 30 gram Has active ingredient Glucocorticoid hormone false Inferred relationship Existential restriction modifier
Salicylic acid 3% / Betamethasone dipropionate 0.05% ointment 30 gram Has active ingredient Betamethasone dipropionate false Inferred relationship Existential restriction modifier
Salicylic acid 3% / Betamethasone dipropionate 0.05% ointment 30 gram Has active ingredient Betamethasone false Inferred relationship Existential restriction modifier
Salicylic acid 3% / Betamethasone dipropionate 0.05% ointment 30 gram Has active ingredient Keratolytic agent false Inferred relationship Existential restriction modifier
Salicylic acid 3% / Betamethasone dipropionate 0.05% ointment 30 gram Has active ingredient Salicylic acid false Inferred relationship Existential restriction modifier
Salicylic acid 3% / Betamethasone dipropionate 0.05% ointment 30 gram Has active ingredient Topical agent false Inferred relationship Existential restriction modifier
Salicylic acid 3% / Betamethasone dipropionate 0.05% ointment 30 gram VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Salicylic acid 3% / Betamethasone dipropionate 0.05% ointment 30 gram VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Salicylic acid 3% / Betamethasone dipropionate 0.05% ointment 30 gram Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Salicylic acid 3% / Betamethasone dipropionate 0.05% ointment 30 gram Has VMP Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and salicylic acid 30 milligram/1 gram conventional release cutaneous ointment true Inferred relationship Existential restriction modifier
Salicylic acid 3% / Betamethasone dipropionate 0.05% ointment 30 gram Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Betamethasone true Inferred relationship Existential restriction modifier
Salicylic acid 3% / Betamethasone dipropionate 0.05% ointment 30 gram Has specific active ingredient Salicylic acid true Inferred relationship Existential restriction modifier
Salicylic acid 3% / Betamethasone dipropionate 0.05% ointment 30 gram Has specific active ingredient Betamethasone dipropionate true Inferred relationship Existential restriction modifier
Salicylic acid 3% / Betamethasone dipropionate 0.05% ointment 30 gram Has dispensed dose form Ointment true Inferred relationship Existential restriction modifier
Salicylic acid 3% / Betamethasone dipropionate 0.05% ointment 30 gram Has basis of strength substance Betamethasone true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Diprosalic 0.05%/3% ointment (Organon Pharma (UK) Ltd) 30 gram Is a True Salicylic acid 3% / Betamethasone dipropionate 0.05% ointment 30 gram Inferred relationship Existential restriction modifier
Diprosalic ointment (PI) (Dowelhurst Ltd) 30 gram Is a True Salicylic acid 3% / Betamethasone dipropionate 0.05% ointment 30 gram Inferred relationship Existential restriction modifier
Diprosalic ointment (PI) (Waymade Ltd) 30 gram Is a True Salicylic acid 3% / Betamethasone dipropionate 0.05% ointment 30 gram Inferred relationship Existential restriction modifier
Diprosalic ointment (Doncaster Pharmaceuticals Ltd) 30 gram Is a True Salicylic acid 3% / Betamethasone dipropionate 0.05% ointment 30 gram Inferred relationship Existential restriction modifier
Diprosalic ointment (Sigma Pharmaceuticals Plc) 30 gram Is a True Salicylic acid 3% / Betamethasone dipropionate 0.05% ointment 30 gram Inferred relationship Existential restriction modifier
Diprosalic ointment (Lexon (UK) Ltd) 30 gram Is a True Salicylic acid 3% / Betamethasone dipropionate 0.05% ointment 30 gram Inferred relationship Existential restriction modifier
Diprosalic ointment (Mawdsley-Brooks & Company Ltd) 30 gram Is a True Salicylic acid 3% / Betamethasone dipropionate 0.05% ointment 30 gram Inferred relationship Existential restriction modifier
Diprosalic ointment (Necessity Supplies Ltd) 30 gram Is a True Salicylic acid 3% / Betamethasone dipropionate 0.05% ointment 30 gram Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start